Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.
Klingenberg
R D
RD
The Division of Gastroenterology, Medical Clinic I, University of Lübeck, Lübeck, Germany.
Homann
N
N
Ludwig
D
D
D000328:Adult; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008201:Lymphangiectasis, Intestinal / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008638:Mesenteric Arteries / Q000000981:diagnostic imaging; D015282:Octreotide / Q000008:administration & dosage*; D055502:Secondary Prevention; D018608:Ultrasonography, Doppler
D003692:Delayed-Action Preparations; D015282:Octreotide